PDCD1 and prostate cancer: We further leveraged the complementary value of DEMs and ARGs and showed that miR-205 could specifically bind the autophagy-related gene NKX2–3, and NKX2–3 may be a potential predictive marker for the efficacy of anti-PD-1 therapy in prostate cancer.